| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/11/2010 | US20100035922 Quinuclidine carbonate salts and medicinal composition thereof |
| 02/11/2010 | US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases |
| 02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
| 02/11/2010 | US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100035812 Modified Bovine G-CSF Polypeptides And Their Uses |
| 02/11/2010 | US20100034890 Combinations of formoterol and fluticasone propionate for asthma |
| 02/11/2010 | US20100034835 Use of inhibitors of leukotriene b4 receptor blt2 for treating asthma |
| 02/11/2010 | US20100034831 Agents that Bind a Target in Pulmonary Tissue for Targeting Respiratory Diseases |
| 02/11/2010 | US20100034823 Crystalline anti-hTNFalpha antibodies |
| 02/11/2010 | US20100034771 Combination Of Cytokine And Cytokine Receptor For Altering Immune System Functioning |
| 02/11/2010 | DE202009010937U1 Monoterpene für die Behandlung von Atemwegserkrankungen, insbesondere von bronchopulmonalen Erkrankungen Monoterpene for the treatment of respiratory disorders, in particular of bronchopulmonary disorders |
| 02/11/2010 | DE102008036725A1 Pharmazeutische Zusammensetzung für die nasale Applikation A pharmaceutical composition for nasal administration |
| 02/11/2010 | CA2733440A1 Respiratory disease treatment |
| 02/11/2010 | CA2733380A1 Quinuclidine carbonate derivatives and medicinal composition thereof |
| 02/11/2010 | CA2732087A1 Substituted naphthyridines and their use as medicaments |
| 02/11/2010 | CA2731926A1 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments |
| 02/11/2010 | CA2725012A1 Methods for treating injury associated with exposure to an alkylating species |
| 02/10/2010 | EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 02/10/2010 | EP2151447A1 Lincomycin derivatives and antibacterial agents containing the same as the active ingredient |
| 02/10/2010 | EP2151436A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 02/10/2010 | EP2151241A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative |
| 02/10/2010 | EP2151236A1 G-protein-conjugated receptor agonist |
| 02/10/2010 | EP1525191B1 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/10/2010 | EP1278546B1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 02/10/2010 | CN100588660C Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/10/2010 | CN100588430C SARS-Cov gene vaccine based on epi-position and its contruction |
| 02/10/2010 | CN100588415C Capsule for treating chronic bronchitis and its preparing method |
| 02/10/2010 | CN100588402C Use of natural mulberry glucoside |
| 02/09/2010 | US7659407 Pharmaceutical compounds |
| 02/09/2010 | US7659303 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 02/09/2010 | US7659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 02/09/2010 | US7659293 α-Amino-N-hydroxy-acetamide derivatives |
| 02/09/2010 | US7659257 Medicament for treating lung cancer |
| 02/09/2010 | US7658934 Chlamydia antigens and protein vaccine |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2451562C Piperazine compound |
| 02/09/2010 | CA2451240C Cyclic diamine compound with 6 membered ring groups |
| 02/09/2010 | CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/09/2010 | CA2440588C Chronotherapeutic dosage forms |
| 02/09/2010 | CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2386297C Bicyclic amino acids as pharmaceutical agents |
| 02/09/2010 | CA2293806C Alpha 1-antitrypsin preparation as well as a method for producing the same |
| 02/04/2010 | WO2010013925A2 Pharmacological composition for prevention and treatment of respiratory disease containing pyrazolopyrimidinone compound or pharmaceutically acceptable salts thereof |
| 02/04/2010 | WO2010013846A1 New therapeutic agent for malignant mesothelioma and immunostimulant |
| 02/04/2010 | WO2010013805A1 Aminopropylidene derivative |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010013078A2 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | WO2010012399A1 Indolylamides as modulators of the ep<sb>2</sb> receptor |
| 02/04/2010 | WO2009146807A8 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes |
| 02/04/2010 | WO2009137611A9 Treatment of pulmonary fungal infection with voriconazole via inhalation |
| 02/04/2010 | WO2008121859A8 Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions |
| 02/04/2010 | US20100029764 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction |
| 02/04/2010 | US20100029754 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 02/04/2010 | US20100029728 Phosphodiesterase inhibitors |
| 02/04/2010 | US20100029720 Carboxamide Derivatives As Muscarinic Receptor Antagonists |
| 02/04/2010 | US20100029719 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/04/2010 | US20100029713 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists |
| 02/04/2010 | US20100029709 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/04/2010 | US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis |
| 02/04/2010 | US20100029697 Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 02/04/2010 | US20100029675 Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use |
| 02/04/2010 | US20100029662 Vasoconstriction compositions and methods of use |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029616 Urotensin ii receptor antagonists |
| 02/04/2010 | US20100029598 Extended Benzamide Derivatives as Modulators of the EP2 Receptor |
| 02/04/2010 | US20100029562 hG31P Expression System |
| 02/04/2010 | US20100028426 Time-specific delayed/pulsatile release dosage forms. |
| 02/04/2010 | US20100028355 Himf and btk in pulmonary, cardiac and inflammation disorders |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028262 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 02/04/2010 | CA2732631A1 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | CA2732282A1 Aminopropylidene derivative |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/03/2010 | EP2148876A1 Pyrazolone derivatives as pde4 inhibitors |
| 02/03/2010 | EP2148868A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators |
| 02/03/2010 | EP2148691A2 Local complement inhibition for treatment of complement-mediated disorders |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN100586948C Crystalline anticholinergic, method for its preparation, and use thereof in medicament preparation |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655681 Administering zonisamide; clearing mucus; protective patches |
| 02/02/2010 | US7655674 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655248 Compositions and methods for treatment of candidiasis |
| 02/02/2010 | US7655226 Treatment of Pompe's disease |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 02/02/2010 | CA2321819C Xylitol compositions for treating upper respiratory conditions |
| 02/02/2010 | CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments |
| 01/28/2010 | WO2010011657A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 01/28/2010 | WO2010011653A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
| 01/28/2010 | WO2010011591A1 Method of treating inflammation disorders using extracts of passion fruit |
| 01/28/2010 | WO2010011581A2 Polysaccharides extract from dendrobium for treating allergic diseases |
| 01/28/2010 | WO2010011349A2 Pyrimidine-2,4-diamine jak2 kinase inhibiting anti-inflammation use |
| 01/28/2010 | WO2009138707A9 Quinuclidine derivatives as muscarinic m3 receptor antagonists |